Literature DB >> 23503804

Signaling network of OSW‑1‑induced apoptosis and necroptosis in hepatocellular carcinoma.

Jichun Jin1, Xinglin Jin, Changshi Qian, Yang Ruan, Hao Jiang.   

Abstract

The compound 3β, 16β, 17α‑trihydroxycholest‑5‑en‑22‑one 16‑O‑(2‑O‑4‑methoxybenzoyl‑β‑D‑xylopyranosyl)‑ (1→3)‑(2‑O‑acetyl‑α‑L‑arabinopyranoside (OSW‑1) is a member of the cholestane saponin family that was created in the bulbs of Ornithogalum saudersiae. OSW‑1 has previously been shown as cytotoxic against numerous types of malignant cells, however, its antitumoral mechanisms remain unclear. The present study aimed to examine the potential changes in the gene expression of a hepatocellular carcinoma (HCC) cell line (Hep3B) incubated with OSW‑1 in vitro. The results showed that OSW‑1 inhibited tumors through invasiveness, angiogenesis, cell polarity and cell adhesion (as shown by Roche NimbleGen gene expression analysis), in addition to inducing apoptosis through the mitochondrial pathway. This affected the expression of a number of core genes in a number of signaling pathways, including WNT, MAPK, VEGF and P53. To the best of our knowledge, the present study is the first to report that OSW‑1, as a molecular compound, induces necroptotic death in hepatocellular carcinoma (HCC).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23503804     DOI: 10.3892/mmr.2013.1366

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

1.  Expression of receptor interacting protein 1 and receptor interacting protein 3 oval cells in a rat model of hepatocarcinogenesis.

Authors:  Marta Wójcik; Ryszard Bobowiec; Urszula Lisiecka; Anna Śmiech
Journal:  Exp Ther Med       Date:  2018-03-22       Impact factor: 2.447

2.  OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis.

Authors:  Mengling Wu; Qianrui Huang; Mengya Liao; Xuyi Wu; Huizhi Xi; Hongbo Ma; Shanrui Li; Yiwen Zhang; Yong Xia
Journal:  Cell Oncol (Dordr)       Date:  2022-09-26       Impact factor: 7.051

3.  NFκB activation demarcates a subset of hepatocellular carcinoma patients for targeted therapy.

Authors:  Vignesh Ramesh; Karthikeyan Selvarasu; Jaishree Pandian; Soundarajan Myilsamy; Chidambaranathan Shanmugasundaram; Kumaresan Ganesan
Journal:  Cell Oncol (Dordr)       Date:  2016-08-25       Impact factor: 6.730

4.  Transient Compound Treatment Induces a Multigenerational Reduction of Oxysterol-Binding Protein (OSBP) Levels and Prophylactic Antiviral Activity.

Authors:  Brett L Roberts; Zachary C Severance; Ryan C Bensen; Anh T Le; Naga Rama Kothapalli; Juan I Nuñez; Hongyan Ma; Si Wu; Shawna J Standke; Zhibo Yang; William J Reddig; Earl L Blewett; Anthony W G Burgett
Journal:  ACS Chem Biol       Date:  2019-01-11       Impact factor: 5.100

5.  Anticancer effects of OSW-1 on glioma cells via regulation of the PI3K/AKT signal pathway: A network pharmacology approach and experimental validation in vitro and in vivo.

Authors:  Zhixin Zhan; Ziqiang Liu; Chaochao Zhang; Haijun Gao; Jiacheng Lai; Yong Chen; Haiyan Huang
Journal:  Front Pharmacol       Date:  2022-09-05       Impact factor: 5.988

Review 6.  Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy.

Authors:  Mao-Bin Meng; Huan-Huan Wang; Yao-Li Cui; Zhi-Qiang Wu; Yang-Yang Shi; Nicholas G Zaorsky; Lei Deng; Zhi-Yong Yuan; You Lu; Ping Wang
Journal:  Oncotarget       Date:  2016-08-30

7.  OSW-1 inhibits tumor growth and metastasis by NFATc2 on triple-negative breast cancer.

Authors:  Xiaorong Ding; Yumei Li; Jun Li; Yongmei Yin
Journal:  Cancer Med       Date:  2020-06-08       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.